Marinus Pharmaceuticals logo
Marinus Pharmaceuticals MRNS
$ 0.25 2.73%

Квартальный отчет 2024-Q3
добавлен 12.11.2024

report update icon

Marinus Pharmaceuticals Мультипликаторы 2011-2024 | MRNS

Мультипликаторы по годам Marinus Pharmaceuticals

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-3.5 -14.4 -4.4 -5.0 -2.1 -3.5 -9.4 -0.8 -3.5 -6.3 -23.6 -46.4 -

P/S

16.0 11.2 28.4 197.3 - - - - - - - 654.1 -

EPS

-2.6 -0.5 -2.7 -2.8 -1.0 -0.9 -0.8 -1.5 -1.7 -2.2 -19.6 - -

EV (Enterprise Value)

530 млн 189 млн 396 млн 214 млн 34.6 млн 69.2 млн 146 млн 6.99 млн 47.1 млн 27.6 млн 117 млн 69.9 млн -

EBITDA per Share

-2.44 -2.88 -2.63 -2.48 -3.97 -3.62 -3.21 -5.79 -6.55 -7.75 -2.79 -0.699 -

EV/EBITDA

-3.8 -3.0 -0.4 -1.7 -7.6 -0.1 -1.7 -2.1 -22.1 -40.3 -

PEG

0.63 -196.4 0.41 -0.17 0.21 0.28 -0.21 -0.07 -0.15 0.03 0.4 1.73 -

P/B

29.6 2.5 8.2 2.5 1.3 1.9 3.0 1.1 1.8 1.7 13.1 15.6 -

P/CF

-4.2 -2.5 -7.9 -5.6 -2.3 -4.7 -9.2 -0.9 -4.2 -7.9 -18.7 -53.0 -

ROE %

-843.45 -17.08 -184.68 -49.18 -61.66 -53.75 -32.58 -133.35 -52.96 -26.32 -55.72 -33.68 -

ROA %

-82.74 -7.64 -72.18 -44.85 -54.76 -48.82 -31.15 -91.08 -41.65 -21.57 -44.57 -16.22 -

ROCE %

-784.28 -97.23 -181.23 -48.62 -59.93 -54.41 -32.76 -120.88 -46.78 -24.74 -56.58 -34.11 -

Current Ratio

1.1 1.8 1.6 13.6 11.7 10.7 21.4 3.7 7.8 24.6 5.0 1.9 -

DSO

59.8 64.3 31.3 349.7 - - - - - - - - -

DIO

- - - - - - - - - - - - -

DPO

- - - - - - - - - - - - -

Операционный цикл

59.8 64.3 31.3 - - - - - - - - - -

Финансовый цикл

59.8 64.3 31.3 - - - - - - - - - -

Все данные представлены в валюте USD

Мультипликаторы поквартально Marinus Pharmaceuticals

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-0.42 -0.63 -0.68 - -0.61 -0.61 -0.67 - 1.93 -1.06 -0.52 - -0.53 -0.65 -0.74 - -0.51 -0.63 -1.27 -0.25 -1.05 -0.24 -0.24 -0.24 -0.27 -0.24 -0.15 -0.12 -0.15 -0.21 -0.26 -0.31 -0.33 -0.46 -0.37 -0.45 -0.35 -0.37 -0.5 -0.26 -0.22 -7.98 -7.09 -5.54 -4.58 -5.66 -3.82 - - - - - - - -

EBITDA per Share

- - -0.63 - - - -0.63 - -0.8 -0.98 -0.45 - -0.51 -0.64 -0.74 - -0.51 -0.63 -0.87 - -1.04 -0.24 -0.24 - -0.28 -0.24 -0.15 - -0.15 -0.2 -0.26 - -0.33 -0.45 -0.36 - -0.39 -0.36 -0.49 - -0.26 -5.88 -5.71 - -2.67 -3.53 - - - - - - - - -

ROE %

286.81 190.06 58.69 -156.97 -67.60 82.24 -683.08 -779.55 -804.40 -918.63 -122.68 -73.45 -84.86 -71.42 -57.78 -36.45 -62.32 -74.08 -83.51 -90.85 -79.79 -72.87 -65.93 -53.75 -47.12 -38.05 -31.98 -32.58 -52.41 -75.32 -109.13 -133.35 -121.57 -102.05 -71.62 -52.96 -45.51 -38.99 -35.83 -26.32 -15.25 -9.17 1.69 7.12 4.81 2.79 - - - - - - - - -

ROA %

-123.79 -102.14 -76.87 -47.60 -7.95 48.12 27.94 -10.15 -22.43 -74.36 -57.37 -51.61 -62.02 -60.15 -51.51 -33.23 -48.82 -52.38 -54.54 -54.76 -52.61 -53.41 -53.47 -48.82 -43.18 -35.29 -30.16 -31.15 -42.46 -56.15 -77.10 -91.08 -84.71 -72.48 -52.86 -41.66 -36.09 -31.09 -28.87 -21.57 -26.18 -33.21 -40.82 -36.37 -24.58 -14.23 - - - - - - - - -

ROCE %

259.61 170.00 47.09 -151.60 -188.30 -166.98 -877.63 -843.54 -867.96 -855.68 -114.91 -72.68 -84.12 -71.14 -58.01 -36.76 -60.09 -71.98 -81.41 -65.39 -81.81 -74.90 -67.90 -39.38 -46.64 -37.48 -31.25 -24.32 -53.97 -76.36 -109.76 -103.87 -114.21 -94.89 -64.74 -36.09 -42.01 -37.60 -34.51 -20.33 -18.14 -10.03 0.62 4.91 4.91 2.72 - - - - - - - - -

Current Ratio

0.5 0.7 0.9 1.1 1.4 1.4 1.6 1.8 1.8 1.1 1.4 1.6 2.0 4.2 7.2 11.3 11.3 11.3 11.3 8.9 8.9 8.9 8.9 10.9 10.9 10.9 10.9 22.8 22.8 22.8 22.8 3.1 3.1 3.1 3.1 4.7 4.7 4.7 4.7 5.5 5.5 5.5 5.5 5.0 5.0 5.0 - - - - - - - - -

DSO

38.9 39.4 43.4 - 59.2 127.0 79.3 - 124.8 139.9 16.5 - 11.2 - 41.6 - 439.2 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DIO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

- - - - - - - - - 311.1 304.3 - 123.6 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Операционный цикл

38.9 39.4 43.4 - 59.2 127.0 79.3 - 124.8 139.9 16.5 - 11.2 - 41.6 - 439.2 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Финансовый цикл

38.9 39.4 43.4 - 59.2 127.0 79.3 - 124.8 -171.2 -287.9 - -112.4 - 41.6 - 439.2 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Все данные представлены в валюте USD